Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for INTEGRIS Southwest Medical Center located at 4401 S Western Ave, Oklahoma City, OK, 73109 & includes data from NPIs 1457372625, 1538587464, 1336252717
Dexur analyzed Q2 2019 (April to June 2019) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for INTEGRIS Southwest Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 1,114 | 1,045 | ||||||||||
Surgical | 234 | 225 | ||||||||||
Non Surgical | 880 | 820 | ||||||||||
General Medicine | 213 | 197 | ||||||||||
Orthopedics | 171 | 166 | ||||||||||
Cardiovascular | 154 | 147 | ||||||||||
Pulmonology | 135 | 121 | ||||||||||
Neurology | 126 | 119 | ||||||||||
Gastroenterology & Endocrinology | 101 | 95 | ||||||||||
General Surgery | 86 | 80 | ||||||||||
Urology | 80 | 77 | ||||||||||
Oncology & Hematology | 24 | 21 |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Aftercare | ||||||||||||
DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
Coronary Bypass | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory Infections And Inflammations |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
Seizures |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Diabetes | ||||||||||||
G.I. Obstruction |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Apr 2019 to Jun 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |